'24/7 unmanned synthesis platform' uses robots and light to produce drug candidates
Even when AI designs molecules with potential as medicines, drug development can be delayed if the process of producing them is slow. KAIST researchers have developed an "unmanned synthesis platform" that uses synthesis robots and light to automatically carry out the entire process from mixing raw materials to synthesis and analysis. The technology is expected to help secure a wider range of drug…
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
